Elevation Oncology common stock slated for Nasdaq removal per Form 25

Rhea-AI Filing Summary

Nasdaq Stock Market LLC has filed Form 25 with the SEC to remove Elevation Oncology, Inc. (ELEV) common stock from listing and registration under Section 12(b) of the Securities Exchange Act of 1934.

The notification, signed by AVP Tara Petta on 23 Jul 2025, states that Nasdaq has reasonable grounds to believe it satisfies all requirements for the filing and has complied with its own rules pursuant to Rule 12d2-2.

Once effective, the filing will strike the company’s sole listed security—its common stock—from Nasdaq’s official list and terminate its Section 12(b) registration.

Positive

• None.

Negative

• Form 25 initiates delisting of ELEV common stock from Nasdaq and withdrawal of Section 12(b) registration, removing the shares from a major exchange.
• Filing provides no explanation for the delisting, leaving investors without clarity on underlying causes.

Insights

Financial Analyst

TL;DR: Nasdaq’s Form 25 signals delisting of ELEV common stock—a clearly negative event for exchange-traded shareholders.

The filing removes Elevation Oncology’s common stock from both Nasdaq listing and Section 12(b) registration. Delisting typically reduces liquidity, analyst coverage, and institutional ownership; although the excerpt doesn’t state the reason, investors usually view involuntary or unclarified delistings unfavorably. The absence of marked rule provisions or explanatory detail leaves uncertainty about compliance or strategic motivations, amplifying risk perception.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-40523

Issuer:	Elevation Oncology, Inc.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	101 Federal Street,
	Suite 1900
	Boston	MASSACHUSETTS	02110
Telephone number:					(716) 371-1125

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common stock

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2025-07-23	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What SEC filing did Nasdaq submit for Elevation Oncology (ELEV)?

Nasdaq filed Form 25 to remove Elevation Oncology’s common stock from listing and Section 12(b) registration.

Which security is affected by the Form 25 for Elevation Oncology?

The filing covers the company’s common stock.

Who signed the Form 25 on behalf of Nasdaq?

The notice was signed by Tara Petta, AVP, on 23 Jul 2025.

Which section of the Exchange Act is referenced in the Form 25?

Section 12(b) of the Securities Exchange Act of 1934.

Which exchange is removing Elevation Oncology’s stock?

The Nasdaq Stock Market LLC is striking the security from its listing.